Reuters: Sanofi mulls nominees for Genzyme board

Suggesting that Sanofi-Aventis is prepping for a possible proxy fight at Genzyme, the French drugmaker has hired a search firm to vet for potential candidates to nominate to Genzyme's board, sources tell Reuters. Report